Overview
- The new scale captures more than 60 biomarkers in about 90 seconds using Impedance Cardiography, Bioimpedance Spectroscopy, pulse wave velocity, and a retractable handle that enables a six‑lead ECG.
- An AI model estimates arterial hypertension risk and flags potential glycemic dysregulation as early warnings rather than diagnostic results.
- A consolidated Health Trajectory score translates the many measurements into a simple view of expected healthspan and progress over time.
- The rechargeable battery is rated for up to 15 months, with data syncing over Wi‑Fi or Bluetooth to the Withings app and integrations through Apple Health and Android Health Connect, including Fitbit.
- The device carries GDPR and HIPAA compliance with ISO 27001/27701 certifications, moves the display into the handle for easier viewing, and is priced at roughly $599–$600 in the U.S.